April 21, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreApril 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreApril 21, 2026
Market insights predict, the resorbable nerve conduits industry is expected to grow from USD 2.49 billion in 2024 to USD 5.28 billion by 2034, driven by a CAGR of 7.8%. The rising demand to treat nerve injuries by reducing the risk of inflammation and regenerating nerve with the presence of foreign body is increasing the adoption of resorbable nerv...
April 21, 2026
According to market projections, the compounding pharmacy sector is expected to grow from USD 13.86 billion in 2024 to USD 22.91 billion by 2034, reflecting a CAGR of 5.15%, tailoring medications for unique patient needs, such as dye allergies or non-pill forms. Valor Compounding Pharmacy and Revelation Pharma recently expanded through partnerships...
April 21, 2026
Androgenetic alopecia, a genetic condition causing gradual hair loss, affects up to 50% of men and women, with Caucasians showing the highest prevalence. In 2024, Pelage Pharmaceuticals raised $16.75M for hair loss therapies, while a company raised $4M to treat this genetic condition....
April 21, 2026
RNA-based therapies are rapidly growing, offering new treatment possibilities for diseases like cancer, neurological disorders, and infections. Recent advancements in mRNA, ASO, and siRNA technologies have led to new approvals, with more in development. These therapies offer targeted, risk-free solutions with broad potential....
April 21, 2026
Induced pluripotent stem cells (iPSCs) are versatile cells derived from adult skin or blood, capable of transforming into any cell type. Widely used in regenerative medicine, disease modeling, and drug discovery, iPSCs are driving innovation, fueled by rising R&D and investment in stem cell therapies....
April 21, 2026
Market insights predict, the orthodontics industry is expected to grow from USD 7.65 billion in 2024 to USD 38.21 billion by 2034, driven by a CAGR of 17.45%. The market is growing due to rising awareness of dental aesthetics and increasing demand for cosmetic dentistry. Advancements in technology, like clear aligners and 3D imaging, make treatment...
April 21, 2026
The induced pluripotent stem cells production market size is calculated at $1.82 bn in 2025 is to hit $4.11 bn by 2034. The iPSC production market is advancing rapidly. GC Therapeutics raised $75M to develop "supercell" drugs, while FUJIFILM invested $200M in expanding facilities for iPSC and biologics. AI integration, using ML and DL, enhances iPS...
April 21, 2026
Market insights predict the global non-alcoholic steatohepatitis treatment industry will increase from USD 7.75 billion in 2024 to USD 92.5billion by 2034, achieving a CAGR of 28.14%. North America led the global non-alcoholic steatohepatitis (NASH) treatment market with 79% share in 2024. The rising prevalence of obesity, growing research and...
April 21, 2026
According to market projections, the cancer stem cells sector is expected to grow from USD 3.2 billion in 2024 to USD 8.04 billion by 2034, reflecting a CAGR of 9.64%. Stem cell-based therapies are highly useful in providing high-quality treatment, due to which stem cells are being continuously grown and studied to treat various cancers....
April 21, 2026
The food allergy treatment market size is calculated at $7.47 bn in 2025 is to hit $15.32 bn by 2034. In 2024, notable advancements in food allergy treatment include Mitsubishi Gas Chemical's partnership with Alerje to enhance global allergy care, the U.S. FDA's approval of Xolair for severe allergies, and Inimmune's collaboration with Intrommune t...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
